These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24289726)

  • 1. Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse.
    Doll F; Schwager K; Hemmerle T; Neri D
    Arthritis Res Ther; 2013 Sep; 15(5):R138. PubMed ID: 24289726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis.
    Schwager K; Kaspar M; Bootz F; Marcolongo R; Paresce E; Neri D; Trachsel E
    Arthritis Res Ther; 2009; 11(5):R142. PubMed ID: 19781067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein.
    Lee JH; Cho JH; Yeo J; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
    Biologicals; 2013 Mar; 41(2):77-83. PubMed ID: 23190454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
    Pasche N; Wulhfard S; Pretto F; Carugati E; Neri D
    Clin Cancer Res; 2012 Aug; 18(15):4092-103. PubMed ID: 22693354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antibody-cytokine fusion proteins featuring granulocyte-colony stimulating factor, interleukin-3 and interleukin-4 as payloads.
    Schmid AS; Tintor D; Neri D
    J Biotechnol; 2018 Apr; 271():29-36. PubMed ID: 29438784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced production of anti-etanercept antibody in collagen-induced arthritis.
    Yi H; Kim J; Jung H; Rim YA; Kim Y; Jung SM; Park SH; Ju JH
    Mol Med Rep; 2014 Jun; 9(6):2301-8. PubMed ID: 24718553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6.
    Hess C; Neri D
    Protein Eng Des Sel; 2014 Jun; 27(6):207-13. PubMed ID: 24795343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression.
    Stringhini M; Mock J; Fontana V; Murer P; Neri D
    MAbs; 2021; 13(1):1868066. PubMed ID: 33404287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy.
    Pretto F; Elia G; Castioni N; Neri D
    Cancer Immunol Immunother; 2014 Sep; 63(9):901-10. PubMed ID: 24893857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis.
    Hemmerle T; Doll F; Neri D
    Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12008-12. PubMed ID: 25092334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of PD-L1 blockade with a potency-matched dual cytokine-antibody fusion protein leads to cancer eradication in BALB/c-derived tumors but not in other mouse strains.
    De Luca R; Neri D
    Cancer Immunol Immunother; 2018 Sep; 67(9):1381-1391. PubMed ID: 29971465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis.
    Quattrocchi E; Walmsley M; Browne K; Williams RO; Marinova-Mutafchieva L; Buurman W; Butler DM; Feldmann M
    J Immunol; 1999 Jul; 163(2):1000-9. PubMed ID: 10395698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational Approach.
    Bruijnen STG; Chandrupatla DMSH; Giovanonni L; Neri D; Vugts DJ; Huisman MC; Hoekstra OS; Musters RJP; Lammertsma AA; van Dongen GAMS; Jansen G; Molthoff CFM; van der Laken CJ
    Mol Pharm; 2019 Jan; 16(1):273-281. PubMed ID: 30550295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-based delivery of interleukin-9 to neovascular structures: Therapeutic evaluation in cancer and arthritis.
    Gouyou B; Ongaro T; Cazzamalli S; De Luca R; Kerschenmeyer A; Valet P; Villa A; Neri D; Matasci M
    Exp Biol Med (Maywood); 2021 Apr; 246(8):940-951. PubMed ID: 33475433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade.
    Kaneko K; Williams RO; Dransfield DT; Nixon AE; Sandison A; Itoh Y
    Arthritis Rheumatol; 2016 Feb; 68(2):521-31. PubMed ID: 26315469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer.
    Kim KN; Watanabe S; Ma Y; Thornton S; Giannini EH; Hirsch R
    J Immunol; 2000 Feb; 164(3):1576-81. PubMed ID: 10640777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.
    Schwager K; Bootz F; Imesch P; Kaspar M; Trachsel E; Neri D
    Hum Reprod; 2011 Sep; 26(9):2344-52. PubMed ID: 21705369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
    Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS
    Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity.
    Hess C; Neri D
    Cancer Immunol Immunother; 2015 May; 64(5):635-44. PubMed ID: 25722088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.